|
Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus. Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus. conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus. Clinical research trials and Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus. healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus.. Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus. Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus. clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus. condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus.  Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus.
Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus.
For Condition: Diabetes Mellitus, Type 1
Status: No longer recruiting
Sponsor(s): Eli Lilly and Company ,
Synopsis: This is a research study of a study drug known as LY041001 or human insulin inhalation powder (HIIP). HIIP is a powder form of insulin made to be inhaled through the mouth and into the lungs using a special handheld device.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - You are at least 18 years old. - You have had type 1 diabetes for at least 2 years. - You are injecting insulin lispro (Humalog), an insulin lispro mixture (Humalog Mixture), regular human insulin mixture (Humulin mixture) before meals using a syringe or injection pen, not an insulin pump. - If you are female and could become pregnant, you test negative for pregnancy based on blood test at the beginning of the study, do not intend to become pregnant, and agree to use a form of birth control approved by the investigator during the study. - You have not smoked for at least 1 year, and you agree not to smoke or use smokeless tobacco during the study. Exclusion Criteria: - You have used an experimental drug during the last 30 days or have ever taken part in a study of any type of inhaled insulin. - You have a history of asthma or allergies. - You have a chronic cough. - You have had a kidney transplant, are on dialysis, or have poor kidney function. - You have a history of chest pain, heart attack, or you have a heart condition that limits your physical activity due to discomfort.
Total Enrollment:
Location and Contact Information:
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Denver, Colorado,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Tacoma, Washington,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Greenville, North Carolina,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Salem, Oregon,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Charleston, West Virginia,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Flushing, New York,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Omaha, Nebraska,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Jackson, Mississippi,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
New Hyde Park, New York,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Hollywood, Florida,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Idaho Falls, Idaho,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Hampton, New Hampshire,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
San Diego, California,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Chesterfield, Missouri,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
New Port Richey, Florida,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
San Antonio, Texas,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Pembroke Pines, Florida,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Renton, Washington,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Atlanta, Georgia,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Baltimore, Maryland,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Springfield, Illinois,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Federal Way, Washington,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Columbia, South Carolina,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Ocala, Florida,
United States
For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
Dallas, Texas,
United States
Additional Information:
Study ID Numbers: 6944;
Study Start Date:
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00063128
Other Diabetes Mellitus, Type 1 Studies:
1. Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control
2. Islet Cell Transplantation Alone in Patients with Type I Diabetes Mellitus: steroid-free immunosuppression
3. Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus.
4. Evaluation of the Effect of Pramlintide on Satiety and Food Intake
5. Ingested Interferon Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly Diagnosed Type 1 Diabetes Mellitus
Related Studies:
Other Diabetes Mellitus, Type 1 Clinical Trials
Other California Clinical Trials
Other San Diego Clinical Trials
Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus.
|
|
|
|
|
|
|
|
